Swarajya Logo
  • Morning Brief
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • Our Views
  • Magazine
  • Headlines
  • Store

Krishna Ella

Bharat Biotech's Intranasal COVID-19 Vaccine To Cost Rs 800 For Private Markets, Rs 325 For Govt Supplies

PTI
2y Business
image

Bharat Biotech's Intranasal Covid-19 Vaccine Completes Phase 2 Trials: Krishna Ella

Bhaswati Guha Majumder
3y News Brief
image

Why Adar Poonawalla Should Get Padma Vibhushan This Year

Arihant Pawariya
3y Ideas
image

Bharat Biotech's Krishna Ella Says Company Working On A Combo Of Covaxin And Nasal Vaccine For Booster Dose

Bhaswati Guha Majumder
3y News Brief
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo